Gilead Sciences, Inc. is a premier biopharmaceutical company headquartered in Foster City, California, recognized for its innovative research and development in antiviral therapies, particularly for HIV and hepatitis. Its breakthrough products, including Harvoni and Sovaldi, have revolutionized the treatment landscape for chronic hepatitis C, reflecting the company’s commitment to addressing urgent healthcare challenges. With a robust and expanding therapeutic pipeline, Gilead continues to focus on unmet medical needs, positioning itself as a pivotal force in improving global health outcomes and advancing patient care.

NASDAQ

USA

HEALTHCARE

DRUG MANUFACTURERS - GENERAL

333 LAKESIDE DRIVE, FOSTER CITY, CA, UNITED STATES, 94404

December

$150 Billion

$14.1 Billion

18.78

6.45

$3.14

2.6%

0.349